Skip to content

Preoperative Gabapentin for Acute and Chronic Post-thoracotomy Analgesia

CompletedNot applicableNCT00588159
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

One dose of either gabapentin or placebo will be given to patients prior to thoracotomy. Patients will also receive an epidural infusion, intravenous patient-controlled analgesia with fentanyl, oral acetaminophen and intravenous ketorolac as needed to achieve optimal analgesia. Pain ratings and supplemental medication use will be recorded for 48 hours and will also be assessed at 3 months postoperatively to determine whether the patients who received gabapentin had improved analgesia and/or required less supplemental medication than the placebo group.

Study details

Official title
Preoperative Gabapentin for Acute and Chronic Post-thoracotomy Analgesia: A Randomized, Double-blinded, Placebo-controlled Study
Conditions
Sponsor
Michelle Kinney
Organization
Mayo Clinic
Start date
2007-06
Primary completion
2010-01
Sex
All
Age range
from 45 Years to 75 Years
Healthy volunteers
true
Results posted
Yes, on ClinicalTrials.gov
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion criteria: * Age 45-75 years * Undergoing thoracotomy (lobectomy, segmentectomy, wedge resection) Exclusion criteria: * Undergoing chest wall resection, gastroesophageal surgery * Enrolled in another post-thoracotomy analgesic research protocol * Pre-existing pain syndrome * Current gabapentin or pregabalin therapy * Inability to understand the study protocol * Coagulopathy * Current use of anticoagulants * Allergy to medications on protocol * Creatinine \>1.3 * Moderate or severe aortic stenosis * Severe psychological disorders * Bacteremia, osteomyelitis, or infection at site of thoracic epidural placement * History of previous thoracotomy * Patient declines preoperative epidural catheter placement * Prisoners or other institutionalized individuals * Severe hepatic, renal or cardiovascular disorders * Women who can become pregnant

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00588159